This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Genmab A+s. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: The Innovative Contributions of Frederikke L Egerod
Introduction
Frederikke L Egerod is a notable inventor based in Copenhagen, Denmark. She has made significant strides in the field of biotechnology, particularly in the development of therapeutic antibodies. Her work is crucial in advancing cancer treatment options.
Latest Patents
Frederikke holds a patent related to antibodies that bind to B7H4. This invention includes bispecific antibodies that also bind to CD3. The patent further encompasses pharmaceutical compositions that utilize these antibodies for therapeutic and diagnostic procedures, especially in cancer therapy.
Career Highlights
Frederikke is currently associated with Genmab A/S, a leading biotechnology company. Her role at Genmab allows her to contribute to groundbreaking research and development in the field of immunotherapy.
Collaborations
Frederikke collaborates with talented professionals such as Louise Koopman and Patrick Engelberts. These partnerships enhance the innovative potential of her work and contribute to the success of their projects.
Conclusion
Frederikke L Egerod's contributions to the field of biotechnology, particularly through her patent on antibodies, highlight her role as an influential inventor. Her work at Genmab A/S and collaborations with esteemed colleagues further underscore her impact on cancer therapy advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile